Amrize Ltd (AMRZ) Stock Price & Analysis
Amrize Ltd (AMRZ) closed at USD 39.44 on Thursday, October 22, 2026, up 1.65% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 38.8; the Oct 22, 2026 session ranged USD 38.43–39.53 on volume of 3,109,219 shares. Market capitalization is $21.57B, with a 52-week range of USD 35.79–65.94 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:23 UTC.
Also available as compact Markdown for AI agents: nexqual.com/AMRZ.md
Key facts (AMRZ)
- Last four reported quarters (through Jun 30, 2026): revenue $12.2B, net income $1.22B (10.0% margin), free cash flow $1.31B (SEC filings).
- Valuation: P/E 17.7x (avg 25.3x at the last 1 fiscal year-ends), EV/EBITDA 9.7x, net debt $4.54B.
- 2 of 80 tracked superinvestors hold AMRZ (13F, Q2 2026): 1 new, 1 added, 0 reduced, 0 unchanged.
- Insider open-market purchases, last ~7 months: 17 Form 4 filings, $5.4M; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 2.55 on a 1–5 scale) (20 analysts), mean target USD 46.62 (range 32–64).
- Total return with dividends: 1Y -17.5% vs S&P 500 +14.9%; 5Y -18.5% vs S&P 500 +80.3%.
- Next earnings: 2026-10-28, EPS estimate USD 1, revenue estimate $3.83B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (AMRZ)
| USD | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|
| Revenue | $11.7B | $11.7B | $11.8B | $12.2B |
| Gross profit | $2.77B | $3.07B | $3.03B | — |
| Operating income | $1.89B | $2.19B | $1.91B | $1.89B |
| Net income | $956M | $1.27B | $1.19B | $1.22B |
| EPS (diluted) | $1.73 | $2.30 | $2.14 | — |
| Free cash flow | $1.41B | $1.64B | $1.42B | $1.31B |
| Gross margin | 23.7% | 26.2% | 25.7% | — |
| Operating margin | 16.2% | 18.8% | 16.1% | 15.5% |
| Net margin | 8.2% | 10.9% | 10.0% | 10.0% |
| Revenue growth | — | +0.2% | +0.9% | — |
| Cash + short-term investments | $1.11B | $1.58B | $1.92B | — |
| Total debt | — | — | $5.27B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (AMRZ)
P/E 17.7x · P/S 1.8x · EV/EBITDA 9.7x · EV/Sales 2.1x · P/FCF 16.4x · P/B 1.7x · FCF yield 6.09% · Earnings yield 5.64% · Net debt $4.54B · EV $26.1B
P/E at fiscal year-ends: Dec 2025 25.3x.
Superinvestors (SEC 13F-HR, Q2 2026) (AMRZ)
2 of 80 tracked investors hold AMRZ. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Pacific Advisors | 2.13% | $169M | Added +1.0% | |
| Leon Cooperman | Omega Family Office | 1.32% | $46.9M | New position |
Insider purchases (SEC Form 4, open-market, last ~7 months) (AMRZ)
17 purchases, $5.4M. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-09-02 | Jenisch Jan Philipp | Chairman & CEO | 30,000 | $1.3M | 42.47 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-08-27 | Gibson Dwight Audley Konrad | Director | 5 | $0K | 44.58 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-26 | Sanche Jacques Wolf | Director | 4,150 | $187K | 45.02 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-25 | Singleton Denise R | Chief Legal Officer & Corp Sec | 3,500 | $154K | 44.12 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-08-25 | Forrest Nollaig | Chief Mktg & Corp Affairs Off | 1,500 | $66K | 44.15 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-17 | Poletti Samuel Jonas | Chief Strategy & M&A Officer | 2,510 | $118K | 46.92 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-08-11…2026-08-12 | Oran Baris | Chief Financial Officer | 6,000 | $284K | 47.26 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-11 | Clark Stephen S | Chief People Officer | 5,260 | $249K | 47.31 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-08-11 | Brouwer Roald | Chief Technology Officer | 1,500 | $70K | 46.36 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-08-11 | Gross Mario | Chief Supply Chain Officer | 3,568 | $166K | 46.6 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-08-11 | Hill Jaime | President, Building Materials | 1,500 | $71K | 47.12 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-22 | Forrest Nollaig | Chief Mktg & Corp Affairs Off | 2,000 | $101K | 50.25 | Too little history (no open-market trades in 2023–2025) |
| 2026-05-21 | Brouwer Roald | Chief Technology Officer | 1,500 | $75K | 49.84 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-19…2026-05-20 | Gross Mario | Chief Supply Chain Officer | 4,000 | $196K | 49.01 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-19 | Jenisch Jan Philipp | Chairman & CEO | 19,001 | $938K | 49.39 | Too little history (no open-market trades in 2023 or 2024) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (AMRZ)
Consensus Hold (mean 2.55 on a 1–5 scale), 20 analysts; mean target USD 46.62 (low 32, high 64).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Barclays | Target lowered | Equal-Weight | $55 → $40 |
| 2026-10-13 | JP Morgan | Target lowered | Neutral | $52 → $48 |
| 2026-10-12 | Longbow Research | Initiated | Buy | |
| 2026-10-09 | RBC Capital | Target lowered | Underperform | $48 → $32 |
| 2026-10-05 | Wells Fargo | Target lowered | Equal-Weight | $44 → $40 |
| 2026-10-05 | Truist Securities | Target lowered | Hold | $48 → $35 |
| 2026-10-02 | Citigroup | Target lowered | Buy | $58 → $50 |
| 2026-10-01 | Barclays | Initiated | Equal-Weight | $55 |
| 2026-09-23 | Deutsche Bank | Target lowered | Buy | $64 → $56 |
| 2026-09-22 | UBS | Target lowered | Neutral | $57 → $42 |
| 2026-09-18 | Oppenheimer | Target lowered | Outperform | $62 → $55 |
| 2026-09-09 | Wells Fargo | Downgrade | Overweight → Equal-Weight | $55 → $44 |
Total return (dividends reinvested) (AMRZ)
| 1Y (from 2025-10-23) | 5Y (from 2025-06-23) | |
|---|---|---|
| Total return | -17.5% | -18.5% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -17.6% | -14.3% |
| Volatility (annualized) | 37.0% | 32.4% |
| Max drawdown | -44.5% (Feb 2026→Oct 2026) | -43.7% (Feb 2026→Oct 2026) |
AMRZ revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Building Materials | $2.44B | 70.0% | +8.2% |
| Building Envelope | $1.05B | 30.0% | +9.4% |
| Total revenue | $3.49B | 100% | — |
AMRZ revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Aggregates and other construction materials | $1.30B | 37.3% | +6.9% |
| Cement | $1.29B | 37.0% | +9.0% |
| Total revenue | $3.49B | 100% | — |
AMRZ revenue by region (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| United States | $9.11B | 77.1% | +0.9% |
| Central Region | $3.62B | 30.7% | -4.8% |
| Southern Region | $3.53B | 29.9% | +11.5% |
| Canada | $2.67B | 22.6% | -0.1% |
| Great Lakes Region | $2.42B | 20.5% | -7.9% |
| Northeastern Region | $1.88B | 15.9% | -3.1% |
| Pacific Region | $1.33B | 11.3% | +5.9% |
| Other Geographical Regions | $29.0M | 0.2% | — |
| Total revenue | $11.81B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
AMRZ company outlook (results filed Aug 6, 2026)
- “Jan Jenisch, Chairman and CEO: "We delivered strong revenue growth of 8.6% in the second quarter driven by increased mega-project demand from data centers and energy to advanced manufacturing plants and infrastructure modernization.”
- “Full Year 2026 Financial Guidance5 Amrize is updating its FY 2026 financial guidance reflecting increased demand and oil price driven cost inflation.”
- “Amrize is making good progress with its ASPIRE program and expects to achieve $80 million of savings in 2026.”
- “The company invested $241 million and $511 million in capital expenditures, net for the three and six months ended June 30, 2026, respectively, and expects to invest approximately $900 million in 2026 to expand production, increase operational efficiency and best serve customers.”
Quoted word-for-word from the SEC 8-K results press release.
AMRZ analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.00 | $1.16 | -14.0% | $3.83B | 8 |
| Next quarter (ends Dec 2026) | $0.64 | $0.78 | -17.2% | $2.99B | 8 |
| Current fiscal year (ends Dec 2026) | $2.42 | $2.68 | -9.8% | $12.51B | 17 |
| Next fiscal year (ends Dec 2027) | $2.70 | $3.10 | -12.9% | $13.05B | 17 |
AMRZ options: expected move
Options price a move of about ±8.9% (±$3.53) by Nov 20, 2026, which includes earnings on Oct 28, 2026. Over the last 5 reports the stock moved ±7.9% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 39.2% | ±8.9% |
| Dec 18, 2026 | 56 | 40.0% | ±12.7% |
| Jan 15, 2027 | 84 | 35.0% | ±13.4% |
| Apr 16, 2027 | 175 | 32.8% | ±18.1% |
| Jun 17, 2027 | 237 | 35.2% | ±22.6% |
30-day implied volatility 37.8% vs 24.8% realized over the last 30 trading days. Put/call ratio (volume) 2.29. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:23 UTC)
| Price | USD 39.44 |
|---|---|
| Change | ▲ 1.65% (up) |
| Previous Close | USD 38.8 |
| Open | USD 38.61 |
| Day Range | USD 38.43 – 39.53 |
| 52-Week Range | USD 35.79 – 65.94 |
| Volume | 3,109,219 shares |
| Market Cap | $21.57B |
| Exchange | NYQ |
Technical Analysis (AMRZ)
Nexqual's technical model rates AMRZ "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:23 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 53.62 (neutral) |
| vs SMA50 | Below (USD 40.36) |
| MACD | -0.47 (negative) |
Analyst Ratings (AMRZ)
Wall Street analysts rate AMRZ "Hold" based on 20 analysts, with a mean price target of USD 46.62 (range USD 32–64), per Nexqual as of October 23, 2026 at 09:23 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 20 |
| Mean Target | USD 46.62 |
| High Target | USD 64 |
| Low Target | USD 32 |
| Buy / Hold / Sell | 10 / 8 / 2 |
Earnings (AMRZ)
| Next Earnings Date | 2026-10-28 |
|---|---|
| EPS Estimate | USD 1.05 |
| Revenue Estimate | $3.83B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.86 vs est 0.94 ▼ miss |
| 2026-03-31 | USD -0.21 vs est -0.15 ▼ miss |
| 2025-12-31 | USD 0.54 vs est 0.64 ▼ miss |
| 2025-09-30 | USD 0.98 vs est 1.02 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
Financials & Fundamentals (AMRZ)
| Total Revenue | $12.18B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +8.60% |
| Gross Margin | +25.09% |
| Operating Margin | +20.49% |
| Profit Margin | +10.14% |
| ROE | +9.72% |
| Debt / Equity | 0.55 |
| Current Ratio | 1.1 |
| Total Cash | $729.00M |
| Total Debt | $7.09B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.31B (10.8% of revenue) |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
Financial Health Score (AMRZ)
Nexqual rates Amrize Ltd's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:23 UTC.
| Growth | Mixed — Revenue +0.9% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 25%, operating 20% (last 12 months) |
| Balance Sheet | Solid — $729M cash and investments vs $5.27B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $1.31B (last 4 quarters to Jun 2026, SEC), 11% margin |
| Efficiency | Mixed — ROE 10%, ROA 5.0% |
Ownership (AMRZ)
| Insider Ownership | +7.38% |
|---|---|
| Institutional Ownership | +51.19% |
| Shares Outstanding | 546.93M |
| Float | 486.56M |
| Short % of Float | +2.05% |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
Leadership (AMRZ)
Amrize Ltd is led by Jan Philipp Jenisch, CEO & Chairman, per Nexqual as of October 23, 2026 at 09:23 UTC.
| CEO & Chairman | Jan Philipp Jenisch |
|---|---|
| President of Building Materials | Jaime Hill |
| Chief Financial Officer | Samuel J. Poletti |
| Chief Technology Officer | Roald Brouwer |
| Vice President of Investor Relations | Dillon Gerard Cumming |
Major Backers & Investors (AMRZ)
Notable institutional backers of Amrize Ltd include NORGES BANK, Harris Associates L.P., Artisan Partners Funds Inc.-Artisan International Value Fund, according to Nexqual as of October 23, 2026 at 09:23 UTC.
Active Investors
| Investor | Stake |
|---|---|
| NORGES BANK | 2.48% |
| Harris Associates L.P. | 2.47% |
| Artisan Partners Funds Inc.-Artisan International Value Fund | 2.17% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1.91% |
| Invesco | 1.52% |
| UBS Group AG | 1.46% |
| Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 1.33% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 5.06% |
| BlackRock | 2.85% |
| Geode Capital | 1.1% |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
From Amrize Ltd's Latest SEC 10-K Filing (filed 2026-02-18)
Key Strengths & Strategy (as disclosed to the SEC)
- Where appropriate, we supplement our owned intellectual property portfolio by licensing intellectual property from third parties, including Holcim, and seek to protect our trade secrets and other confidential and proprietary information through internal controls, contractual protections and confidentiality agreements with our employees and third-party service providers. demand.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| JHX | James Hardie Industries plc. | USD 26.54 | ▲ 0.91% |
| CX | Cemex, S.A.B. de C.V. Sponsored | USD 10.11 | ▼ 2.69% |
| VMC | Vulcan Materials Company (Holdi | USD 268.72 | ▲ 1.54% |
| MLM | Martin Marietta Materials, Inc. | USD 517.67 | ▲ 1.7% |
| CRH | CRH PLC | USD 86.43 | ▲ 0.46% |
| EXP | Eagle Materials Inc | USD 178.74 | ▲ 3.09% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:23 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt